Atef Lina Mohammed, Mohammed Ghada Farouk, Al-Dhubaibi Mohammed Saleh, Soliman Mahmoud, Bahaj Saleh Salem, Saleh Yasser S N
Department of Dermatology, Venereology and Sexology, Faculty of Medicine, Suez Canal University, Ismailia, 41522, Egypt.
Dermatology, Department of Medicine, College of Medicine, Shaqra University, Dawadmi, 11961, Saudi Arabia.
Sex Med. 2024 Oct 1;12(5):qfae067. doi: 10.1093/sexmed/qfae067. eCollection 2024 Oct.
Hormonal, behavioral, psychological, surgical, and pharmacopsychological treatment approaches contribute to female sexual dysfunction (FSD). The study is conducted to assess the effectiveness of hyaluronan high and low molecular weight hybrid cooperative complexes (hybrid H-HA/L-HA) in treating females with SD and to compare the female sexual function index (FSFI), dermatological life quality index (DLQI), and female genital self-image scale (FGSIS) before and after therapy.
We divided the 60 female participants into two groups. Hybrid H-HA/L-HA was administered to form pili of 0.25 cc around the clitoris in the direction of clock positions of 12, 3, 6, and 9. In Skene's gland; 0.25 cc for each and 0.5 cc into the corpus/body of the clitoris. Two treatments were held 30 days apart.The same procedure was repeated on the control group, but with saline as a placebo.
Women completed self-report questionnaires assessing sexual functioning using the FSFI, DLQI, and FGSIS before and after therapy.
There was a significant ( = 634.152; < .05) increase in the study group's weekly sexual interactions compared with the controls. The study group showed statistically significant amelioration in desire, arousal, lubrication, orgasm, satisfaction domains, overall score, and a decrease in pain following the first and second injection sessions ( = .014, .031, .003, .001, .011, .004, and .011, respectively). A comparison of the results between the two groups revealed significant improvement were found ( = .025).There were significant improvements in the domains of the FGSIS compared with the controls ( = .026). The study group showed a substantial improvement in satisfaction with the way their genital area looked, comfort level when allowing a sexual partner to view their genital area, belief that their genitals smell perfectly fine without being self-conscious about them, and overall score ( = .022, .031, .003, .001, and .004, respectively) ( < .05).The hybrid H-HA/L-HA sessions resulted in significantly greater positive perceptions and feelings, leisure activities, interpersonal interactions, and general assessments ( = .021, .021, and .020, respectively) ( < .05).
Female individuals with SD experience sexual improvements after hybrid H-HA/L-HA injection.
This is the first study focusing on female individuals with SD. We recommend conducting the study on a larger population and including their partners.
Hybrid H-HA/L-HA injection for rejuvenating the clitoral injection appears to be a reliable and safe method for enhancing female genital self-image, sexuality, and quality of life.
激素、行为、心理、手术及药物心理治疗方法都与女性性功能障碍(FSD)有关。本研究旨在评估高分子量与低分子量透明质酸混合协同复合物(混合H-HA/L-HA)治疗性功能障碍女性的有效性,并比较治疗前后的女性性功能指数(FSFI)、皮肤病生活质量指数(DLQI)和女性生殖器自我形象量表(FGSIS)。
我们将60名女性参与者分为两组。在阴蒂周围按照12、3、6和9点的时钟位置方向注射0.25 cc混合H-HA/L-HA形成丘疹。在斯基恩氏腺处,各注射0.25 cc,在阴蒂体注射0.5 cc。两次治疗间隔30天。对照组重复相同操作,但使用生理盐水作为安慰剂。
女性在治疗前后使用FSFI、DLQI和FGSIS完成了评估性功能的自我报告问卷。
与对照组相比,研究组每周的性互动有显著增加(=634.152;<0.05)。在第一次和第二次注射后,研究组在性欲、性唤起、润滑、性高潮、满意度领域、总分方面有统计学意义的改善,疼痛减少(分别为=0.014、0.031、0.003、0.001、0.011、0.004和0.011)。两组结果比较显示有显著改善(=0.025)。与对照组相比,FGSIS各领域有显著改善(=0.026)。研究组在对其生殖器区域外观的满意度、允许性伴侣查看其生殖器区域时的舒适度、相信其生殖器气味良好且无需为此感到难为情以及总分方面有显著改善(分别为=0.022、0.031、0.003、0.001和0.004)(<0.05)。混合H-HA/L-HA治疗带来了显著更多的积极认知和感受、休闲活动、人际互动及总体评价(分别为=0.021、0.021和0.020)(<0.05)。
患有性功能障碍的女性个体在注射混合H-HA/L-HA后性功能得到改善。
这是第一项针对患有性功能障碍女性个体的研究。我们建议对更大规模人群进行研究并纳入其伴侣。
用于使阴蒂注射恢复活力的混合H-HA/L-HA注射似乎是增强女性生殖器自我形象及性功能和生活质量的可靠且安全的方法。